Clinical Trial Update: Clinical Validation of ColonAiQ (a Blood-based Assay Targeting ctDNA Methylation) for Colorectal Cancer Detection

View source ↗

Summary

The document reports the completion of a clinical validation study for ColonAiQ, a blood-based assay targeting ctDNA methylation for colorectal cancer detection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ColonAiQ

Snippet

Sponsor: Singlera Genomics Inc. | Conditions: Colorectal Cancer | Status: COMPLETED